These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 14758164

  • 1. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Fulia F, Cuzzocrea E, Di Rosa M, Caputi AP, Thiemermann C.
    Crit Care Med; 2004 Feb; 32(2):457-66. PubMed ID: 14758164
    [Abstract] [Full Text] [Related]

  • 2. Erythropoietin reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S, Di Paola R, Mazzon E, Patel NS, Genovese T, Muià C, Crisafulli C, Caputi AP, Thiemermann C.
    Crit Care Med; 2006 Apr; 34(4):1168-77. PubMed ID: 16484922
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock.
    Cuzzocrea S, Mazzon E, Di Paola R, Genovese T, Serraino I, Dugo L, Cuzzocrea E, Fulia F, Caputi AP, Salvemini D.
    Crit Care Med; 2004 Jan; 32(1):157-67. PubMed ID: 14707575
    [Abstract] [Full Text] [Related]

  • 4. Ethyl pyruvate reduces the development of zymosan-induced generalized inflammation in mice.
    Di Paola R, Mazzon E, Genovese T, Crisafulli C, Bramanti P, Caminiti R, Esposito E, Fink MP, Cuzzocrea S.
    Crit Care Med; 2009 Jan; 37(1):270-82. PubMed ID: 19050619
    [Abstract] [Full Text] [Related]

  • 5. Absence of peroxisome proliferators-activated receptors (PPAR)alpha enhanced the multiple organ failure induced by zymosan.
    Di Paola R, Esposito E, Mazzon E, Genovese T, Muià C, Crisafulli C, Malleo G, Sessa E, Meli R, Cuzzocrea S.
    Shock; 2006 Nov; 26(5):477-84. PubMed ID: 17047518
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D, Zeng BX, Zhang SH, Yao SL.
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [Abstract] [Full Text] [Related]

  • 11. The tyrosine kinase inhibitor tyrphostin AG 126 reduces the multiple organ failure induced by zymosan in the rat.
    Dugo L, Chatterjee PK, Mazzon E, McDonald MC, Paola RD, Fulia F, Caputi AP, Thiemermann C, Cuzzocrea S.
    Intensive Care Med; 2002 Jun; 28(6):775-88. PubMed ID: 12107686
    [Abstract] [Full Text] [Related]

  • 12. Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Maffia P, Patel NS, Di Paola R, Ialenti A, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Eur J Pharmacol; 2004 Jan 01; 483(1):79-93. PubMed ID: 14709329
    [Abstract] [Full Text] [Related]

  • 13. Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.
    Cuzzocrea S, Rossi A, Pisano B, Di Paola R, Genovese T, Patel NS, Cuzzocrea E, Ianaro A, Sautebin L, Fulia F, Chatterjee PK, Caputi AP, Thiemermann C.
    Intensive Care Med; 2003 Nov 01; 29(11):2016-25. PubMed ID: 12879239
    [Abstract] [Full Text] [Related]

  • 14. Glycogen synthase kinase 3beta inhibition reduces the development of nonseptic shock induced by zymosan in mice.
    Cuzzocrea S, Di Paola R, Mazzon E, Crisafulli C, Genovese T, Muià C, Abdelrahman M, Esposito E, Thiemermann C.
    Shock; 2007 Jan 01; 27(1):97-107. PubMed ID: 17172987
    [Abstract] [Full Text] [Related]

  • 15. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats.
    Ito K, Shimada J, Kato D, Toda S, Takagi T, Naito Y, Yoshikawa T, Kitamura N.
    Eur J Cardiothorac Surg; 2004 Apr 01; 25(4):530-6. PubMed ID: 15037267
    [Abstract] [Full Text] [Related]

  • 16. Etanercept reduces acute tissue injury and mortality associated to zymosan-induced multiple organ dysfunction syndrome.
    Malleo G, Mazzon E, Genovese T, Di Paola R, Muià C, Caminiti R, Esposito E, Di Bella P, Cuzzocrea S.
    Shock; 2008 May 01; 29(5):560-71. PubMed ID: 17724436
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y, Yin W, Signore AP, Zhang F, Hong Z, Wang S, Graham SH, Chen J.
    J Neurochem; 2006 Apr 01; 97(2):435-48. PubMed ID: 16539667
    [Abstract] [Full Text] [Related]

  • 18. Protective effect of Hypericum perforatum in zymosan-induced multiple organ dysfunction syndrome: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity.
    Di Paola R, Mazzon E, Muià C, Crisafulli C, Genovese T, Di Bella P, Esposito E, Menegazzi M, Meli R, Suzuki H, Cuzzocrea S.
    Nitric Oxide; 2007 Feb 01; 16(1):118-30. PubMed ID: 16889996
    [Abstract] [Full Text] [Related]

  • 19. Rosiglitazone, a PPAR-gamma ligand, protects against burn-induced oxidative injury of remote organs.
    Sener G, Sehirli AO, Gedik N, Dülger GA.
    Burns; 2007 Aug 01; 33(5):587-93. PubMed ID: 17467912
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.